Annotation Detail

Information
Associated Genes
INS
Associated Variants
CAD c.2288-1552T>C ( ENST00000264705.9, ENST00000403525.5 )
GTF3C2 p.Pro782= (p.P782=) ( ENST00000264720.8, ENST00000359541.6 )
rs6547626
GCKR c.1423-418T>C ( ENST00000264717.7 )
SPATA31H1 c.145-13502T>G ( ENST00000447166.3 )
GPN1 c.*259C>G ( ENST00000264718.7, ENST00000424214.5, ENST00000458167.6, ENST00000610189.2, ENST00000616939.4 )
CAD c.2288-1552T>C ( ENST00000264705.9, ENST00000403525.5 )
GTF3C2 p.Pro782= (p.P782=) ( ENST00000264720.8, ENST00000359541.6 )
rs6547626
GCKR c.1423-418T>C ( ENST00000264717.7 )
SPATA31H1 c.145-13502T>G ( ENST00000447166.3 )
GPN1 c.*259C>G ( ENST00000264718.7, ENST00000424214.5, ENST00000458167.6, ENST00000610189.2, ENST00000616939.4 )
Associated Disease
Kidney Diseases
Source Database
DisGeNET
Description
In 509 GAD-negative patients with newly diagnosed type 2 diabetes, we 1) genotyped six single nucleotide polymorphisms in GCKR genomic region: rs6717980, rs1049817, rs6547626, rs780094, rs2384628, and rs8731; 2) assessed clinical phenotypes, insulin sensitivity by the euglycemic insulin clamp, and β-cell function by state-of-the-art modeling of glucose/C-peptide curves during an oral glucose tolerance test; and 3) estimated glomerular filtration rate (eGFR) by the Modification of Diet in Renal Disease formula.
Pubmed
21411509
Original source reporting the Gene Disease association
BeFree
DisGENET score for the Gene Disease association
0.0119434423715333
Year of publication
2011
Drugs